Tatva Chintan Pharma Chem Limited / Fundamentals
Income statement
- Net revenue
€37.48M - Cost of goods sold
€21.38M - Gross profit
€16.10M - SG&A expenses
€1.83M - R&D expenses
€0.00 - EBITDA
€3.47M - D&A
€2.68M - EBIT
€4.01M - Interest expenses
€126.34K - EBT
€742.36K - Tax expenses
€182.85K - Net income
€559.51K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€559.51K - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€1.38M - Cash and short-term investments
€1.38M - Total receivables
€8.08M - Inventory
€13.12M - Other current assets
€3.40M - Total current assets
€25.98M - Property, plant & equipment
€53.58M - Goodwill
€0.00 - Intangible assets
€577.73K - Long-term investments
€0.00 - Other non-current assets
€1.76M - Total non-current assets
€55.92M - Total assets
€81.90M - Accounts payable
€3.20M - Short-term debt
€3.56M - Other current liabilities
€2.64M - Total current liabilities
€9.40M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€136.91K - Total non-current liabilities
€136.91K - Total liabilities
€9.54M - Common stock
€2.29M - Retained earnings
€0.00 - Other equity
€70.07M - Total equity
€72.36M - Total liabilities and shareholders' equity
€81.90M
Company information
- Market capitalization
€217.55M - Employees
689 - Enterprise Value
€21.66B
Company ratios
- Gross margin
-
43.0% Worse than peer group: 49.6% - EBITDA margin
-
9.3% Worse than peer group: 28.1% - EBIT margin
-
10.7% Worse than peer group: 22.8% - EBT margin
-
2.0% Much worse than peer group: 22.6% - Net margin
-
1.5% Worse than peer group: 16.9% - ROE
-
0.8% Worse than peer group: 18.4% - ROA
-
0.7% Worse than peer group: 11.2% - Asset turnover
-
45.8% Much worse than peer group: 72.6% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
90.7% - Net sales per employee
-
€54.40K - Net income per employee
-
€812.06